US2008166320A1PendingUtilityA1
Geldanamycin-producing strains, uses thereof and methods of producing same
Est. expiryDec 8, 2023(expired)· nominal 20-yr term from priority
C12R 2001/465C12N 1/205A61P 43/00A01N 63/28
39
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A use of an inoculum of a geldanamycin-producing strain able to survive in a plant rhizosphere as a biocontrol of common scab affecting the plant and a method for biocontrolling common scab comprising the use of such strain. A biologically pure culture of a Streptomyces strain deposited at the American Type Culture Collection (ATCC) Accession number BAA-668, or a variant thereof.
Claims
exact text as granted — not AI-modified1 .- 3 . (canceled)
4 . A method of biocontrolling common scab comprising applying on a plant an effective amount of an inoculum of a geldanamycin-producing strain able to survive in the plant rhizosphere.
5 . The method of claim 4 , wherein said strain encodes a protein having the sequence of SEQ ID NO: 6 or an homologous sequence having geldanamycin activity.
6 . The method of claim 4 , wherein said strain comprises the nucleotide sequence of SEQ ID NO: 7 or an homologous sequence having geldanamycin activity.
7 . The method of claim 4 , wherein said strain comprises a nucleotide sequence able to hybridize under high stringency conditions to the complementary sequence of a sequence selected from the group consisting of:
a) the nucleotide sequence of SEQ ID NO: 1; b) the nucleotide sequence of SEQ ID NO: 2; c) the nucleotide sequence of SEQ ID NO: 3; d) the nucleotide sequence of SEQ ID NO: 5; and e) the nucleotide sequence of SEQ ID NO: 7.
8 . The method of claim 4 , wherein said strain comprises a nucleotide sequence able to hybridize under high stringency conditions to the complementary sequence of the nucleotide sequence of SEQ ID NO: 1.
9 . The method of claim 4 , wherein said strain comprises a nucleotide sequence able to hybridize under high stringency conditions to the complementary sequence of the nucleotide sequence of SEQ ID NO: 2.
10 . The method of claim 4 , wherein said strain comprises a nucleotide sequence able to hybridize under high stringency conditions to the complementary sequence of the nucleotide sequence of SEQ ID NO: 3.
11 . The method of claim 4 , wherein said strain comprises a nucleotide sequence able to hybridize under high stringency conditions to the complementary sequence of the nucleotide sequence of SEQ ID NO: 5.
12 . The method of claim 4 , wherein said strain comprises a nucleotide sequence able to hybridize under high stringency conditions to the complementary sequence of the nucleotide sequence of SEQ ID NO: 7.
13 . The method of claim 4 , wherein said strain is a Streptomyces strain.
14 . The method of claim 4 , wherein said strain is selected from the group consisting of Streptomyces violaceusniger, Streptomyces hygroscopicus and Streptomyces melanosporafasciens strains.
15 . The method of claim 4 , wherein said strain is deposited at the American Type Culture Collection (ATCC) under Accession number BM-668.
16 . The method of claim 4 , wherein said biocontrolling comprises reducing the severity of common scab.
17 . The method of claim 4 , wherein said biocontrolling comprises reducing the incidence of common scab.
18 . A method for modifying the biocontrol efficiency of a bacterial strain comprising intraspecific protoplasm fusion of the bacterial strain with an other strain having a desirable biocontrol property against common scab.
19 . A method for making a biocontrol agent against common scab, which comprises the steps of:
obtaining a microbial strain susceptible of producing geldanamycin; contacting the nucleic acids or the proteins of said strain with a ligand specific to geldanamycin or to a nucleic acid encoding geldanamycin; detecting the formation of a complex as an indication of the presence of geldanamycin or of a nucleic acid encoding geldanamycin in said strain, whereby said strain or a geldanamycin-producing part of said strain may be used as a biocontrol agent against common scab.
20 . The method of claim 19 , wherein said ligand is a nucleic acid having at least 12 nucleotides in length hybridizing with the nucleic acids having a sequence complementary to a sequence selected from:
a) the nucleotide sequence of SEQ ID NO: 1; b) the nucleotide sequence of SEQ ID NO: 2; c) the nucleotide sequence of SEQ ID NO: 3; d) the nucleotide sequence of SEQ ID NO: 5; and e) the nucleotide sequence of SEQ ID NO: 7.Join the waitlist — get patent alerts
Track US2008166320A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.